Difference between revisions of "2011 EHR Quality Measure Spec 0389"

From VistApedia
Jump to: navigation, search
(Added a glossary link to Action~)
 
Line 50: Line 50:
 
'''DEVELOPMENT STATUS''' (Add details here)
 
'''DEVELOPMENT STATUS''' (Add details here)
  
'''ACTION ITEMS / NEXT STEPS''' (Add details here)
+
'''[[ACTION~|Action]] ITEMS / NEXT STEPS''' (Add details here)
  
 
'''PREPARE CERTIFICATION DOCUMENTATION''' (Add details here)
 
'''PREPARE CERTIFICATION DOCUMENTATION''' (Add details here)
  
 
'''OPEN ISSUES / QUESTIONS''' (Add details here)
 
'''OPEN ISSUES / QUESTIONS''' (Add details here)

Latest revision as of 21:47, 29 July 2012

MEASURE # 0389

MEASURE TITLE Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

MEASURE DESCRIPTION Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy who did not have a bone scan performed at any time since diagnosis of prostate cancer

Documents for 2011 EHR-Based Reporting

SPREADSHEET NQF_Retooled_Measure_0389.xlsx

SPREADSHEET GOOGLE DOC URL (editable) http://spreadsheets.google.com/a/worldvista.org/ccc?key=0ArxIkIV4NePEdDM2YUZtMjU5cmY5OWNUQTJaSUdHenc&hl=en&authkey=CI7rxv8M

PDF FILE NAME NQF_HQMF_HumanReadable_0389.pdf

PDF FILE URL https://docs.google.com/fileview?id=14xXZ4W4QVWEeCPs-PtfzCBdpR7F8cVDfodmPFeBQN0AiN3Io8aQ-dFrgx_yK&hl=en

REGARDING MULTIPLE NUMERATORS N/A

TARGET DATE SOLUTION DEVELOPERS STATUS SPEC DEVELOPER NUMERATOR(s) DENOMINATOR(s)
Phase II TBD N/A AMA 1 1

SOLUTION DESIGN / TECHNOLOGY (Add details here)

SOLUTION COMPONENTS (Add details here)

DEPENDENCIES (Add details here)

COMMENTS / NOTES (Add details here)

DEVELOPMENT STATUS (Add details here)

Action ITEMS / NEXT STEPS (Add details here)

PREPARE CERTIFICATION DOCUMENTATION (Add details here)

OPEN ISSUES / QUESTIONS (Add details here)